Coates, L., Rahman, P., Mease, P., Shawi, M., Rampakakis, E., Kollmeier, A., . . . Tam, L. (2024). Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: Post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study. BioMed Central.
Style de citation Chicago (17e éd.)Coates, LC, et al. Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. BioMed Central, 2024.
Style de citation MLA (9e éd.)Coates, LC, et al. Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. BioMed Central, 2024.